Posts

‘Noise-cancelling’ qubits developed at UChicago to mini...

Despite their immense promise to solve new kinds of problems, today’s quantum co...

New variation of the once-obsolete streptothricin shows...

Scientists have been on the lookout for antibiotics against multidrug-resistant ...

Krystal Biotech Gains FDA Green Light For Skin-Disorder...

Vyjuvek, a medication developed by Krystal Biotech, has become the first therapy...

Sanofi finds success in clinical trial for smoker’s lungs

Sanofi has emphasized the rapid and sustained benefits of its collaborative anti...

FTC sues to block Amgen’s $27.8B deal for Horizon

The Federal Trade Commission (FTC) is questioning Amgen’s $27.8 billion acquisit...

Inovio’s INO-3107 receives orphan drug status from EC

INO-3107 also received orphan drug designation from the US Food and Drug Adminis...

Y-mAbs’ Danyelza injection receives marketing approval ...

Danyelza will be given three times in a week to patients and the dosage will be ...

Forge Biologics joins BGTC for new AAV gene therapies d...

BGTC creates a reusable standardised method, which reduces upfront costs and dev...

Supplies of Novo Nordisk’s Wegovy starter doses to be l...

Key opinion leaders (KOLs) interviewed by GlobalData have highlighted that despi...

FDA approves breakthrough pneumonia therapy

The FDA approved Xacduro, developed by Entasis which is now a part of Innoviva, ...

Untangling the Complexities of Cell and Gene Therapy Cl...

By Luisa Sterkel & Joana Loureiro, Tenthpin Consultants The promise and potentia...

Nona Biosciences and ModeX Therapeutics partner for ant...

ModeX will gain access to Nona Bioscience’s fully human Harbour Mice platforms.

CohBar and Morphogenesis in merger for immuno-oncology ...

The combined company will advance Morphogenesis’ personalised cancer vaccines an...

US government plans proposal to push down Medicaid drug...

The Department of Health and Human Services details new plans to survey drug cos...

FDA greenlights new long-term treatment option for opio...

Braeburn’s extended-release injection, Brixadi, joins a growing list of approval...

STAT+: Congress highlighted a chemo drug’s price to bla...

The House Oversight Committee hearing is the latest in a wave of bipartisan cong...